[Form 4] Kindly MD, Inc. Insider Trading Activity
Kindly MD, Inc. (NAKA) insider reported multiple grants to Chief Medical Officer Timothy Pickett on 09/22/2025. The Form 4 shows four non‑derivative transactions reporting the receipt of 37,593 restricted stock units that vest over four years with a 12‑month cliff, plus three fully vested restricted stock awards of 26,129, 10,146, and 18,378 shares, bringing reported beneficial ownership to 191,271 shares after the transactions. All grants were reported with a $0 price, indicating they are equity awards rather than market purchases. The filing is signed by an attorney‑in‑fact on behalf of the reporting person.
Kindly MD, Inc. (NAKA) un insider ha riferito diverse grant al Chief Medical Officer Timothy Pickett il 22/09/2025. Il modulo Form 4 mostra quattro transazioni non derivate relative alla ricezione di 37.593 unità azionarie vincolate che maturano in quattro anni con una cliff di 12 mesi, oltre a tre premi azionari vincolati pienamente maturati di 26.129, 10.146 e 18.378 azioni, portando la proprietà beneficial reporting a 191.271 azioni dopo le transazioni. Tutti i grant sono stati riportati con un prezzo di $0, indicando che si tratta di premi azionari (equity awards) anziché acquisti sul mercato. La dichiarazione è firmata da un attorney-in-fact per conto della persona che presenta la segnalazione.
Kindly MD, Inc. (NAKA) recibió reportes de varios grants al Director Médico Timothy Pickett el 22/09/2025. El Formulario 4 muestra cuatro transacciones no derivativas que reportan la entrega de 37,593 unidades de acciones restringidas que se consolidan durante cuatro años con una cláusula de cliff de 12 meses, además de tres premios de acciones restringidas ya vencidos de 26,129, 10,146 y 18,378 acciones, elevando la propiedad reportada a 191,271 acciones tras las transacciones. Todos los grants se reportaron con un precio de $0, lo que indica que son premios de acciones (equity awards) y no compras en el mercado. La presentación está firmada por un poder judicial o apoderado en nombre de la persona reportante.
Kindly MD, Inc. (NAKA)의 내부자는 2025년 9월 22일 Timothy Pickett Chief Medical Officer에게 다수의 보조금을 보고했습니다. Form 4는 4년 동안 vests되는 37,593주의 제한 주식 단위와 12개월 시점 클리프를 포함한 비파생 거래 4건, 그리고 이미 확정된 26,129, 10,146, 18,378주가 보상으로 각각 지급된 3건의 제한 주식 보상으로 보고되며, 거래 후 보고된 유익 소유 주식 수는 191,271주로 증가합니다. 모든 보상은 시장 매입이 아닌 주식 보상임을 나타내는 $0의 가격으로 보고되었습니다. 해당 filing은 보고 당사자를 대신하여 대리인에 의해 서명되었습니다.
Un initié de Kindly MD, Inc. (NAKA) a reporté plusieurs attributions au Chief Medical Officer Timothy Pickett le 22/09/2025. Le formulaire Form 4 indique quatre transactions non dérivées correspondant à la réception de 37 593 unités d’actions restreintes qui s’acquièrent sur quatre ans avec une cliff de 12 mois, ainsi que trois attributions d’actions restreintes entièrement acquises de 26 129, 10 146, et 18 378 actions, portant la propriété bénéficiaire déclarée à 191 271 actions après les transactions. Tous les attributions ont été signalées à un prix de $0, indiquant qu’il s’agit d’avantages en actions (equity awards) plutôt que d’achats sur le marché. Le dossier est signé par un mandataire au nom de la personne qui déclare.
Ein Insider von Kindly MD, Inc. (NAKA) berichtete am 22.09.2025 über mehrere Zuwendungen an Chief Medical Officer Timothy Pickett. Das Form 4 listet vier nicht-derivative Transaktionen auf, bei denen 37.593 Restricted-Stock-Einheiten gewährt werden, die über vier Jahre mit einem 12-Monats- Cliff vesten, sowie drei vollständig vestierte Restricted-Stock-Boni von 26.129, 10.146 und 18.378 Aktien, wodurch sich das berichtete wirtschaftliche Eigentum nach den Transaktionen auf 191.271 Aktien erhöht. Alle Zuwendungen wurden mit einem Preis von $0 gemeldet, was darauf hinweist, dass es sich um Equity Awards handelt, nicht um Market Purchases. Die Einreichung ist von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.
أبلغ المطلعون في Kindly MD, Inc. (NAKA) عن عدة منح لرئيس الأطباء Timothy Pickett بتاريخ 22/09/2025. يُظهر النموذج 4 أربع معاملات غير مشتقة تُفيد استلام 37,593 وحدة أسهم مقيدة تت vest على مدى أربع سنوات مع حافة 12 شهراً، إلى جانب ثلاث جوائز أسهم مقيدة ناضجة بالكامل من 26,129 و 10,146 و 18,378 سهماً، مما يجعل الملكية المفيدة المبلغ عنها بعد المعاملات تبلغ 191,271 سهماً. جميع المنح أُبلغت بسعر صفري يدل على أنها مكافآت أسهم وليست عمليات شراء في السوق. يتم توقيع الملف من قبل وكيل نيابة باسم الشخص المبلغ.
Kindly MD, Inc. (NAKA) 的内部人士于 2025-09-22 向首席医疗官 Timothy Pickett 报告了多项授予。 Form 4 显示四笔非衍生交易，报告收到 37,593 股受限制的股票单位，分四年 vest，且设有 12 个月悬崖期，此外还有三项已全部归属的受限制股票奖励，分别为 26,129、10,146、18,378 股，交易后的报告受益所有权为 191,271 股。所有授予均以 $0 价格报告，表明它们是股权奖励而非市场购买。该备案由代表报告人签署的代理律师签署。
- None.
- None.
Insights
TL;DR: Routine executive equity grants with multi‑year vesting, aligning retention incentives with service.
The Form 4 documents customary equity compensation for the Chief Medical Officer consisting of time‑based restricted stock units and fully vested restricted awards. The 37,593 RSUs include a 12‑month cliff then quarterly vesting over three additional years, which is a standard retention structure intended to tie executive alignment to company performance and tenure. The awards were reported at $0, consistent with compensation grants rather than open‑market trades. From a governance perspective, these disclosures are routine and do not by themselves indicate unusual dilution or related‑party issues.
TL;DR: Non‑cash equity grants increase insider holdings but represent standard compensation, likely neutral for near‑term valuation.
The filing increases the reporting person’s beneficial ownership to 191,271 shares following the September 22, 2025 grants and vesting events. Because the transactions are equity awards reported at no cash price, they represent compensation expense and potential future dilution as RSUs vest, rather than immediate market buys or sales. Absent additional financial context (share count, recent dilution rates, or material corporate events), these transactions appear informational and routine for modeling long‑term share count impacts.
Kindly MD, Inc. (NAKA) un insider ha riferito diverse grant al Chief Medical Officer Timothy Pickett il 22/09/2025. Il modulo Form 4 mostra quattro transazioni non derivate relative alla ricezione di 37.593 unità azionarie vincolate che maturano in quattro anni con una cliff di 12 mesi, oltre a tre premi azionari vincolati pienamente maturati di 26.129, 10.146 e 18.378 azioni, portando la proprietà beneficial reporting a 191.271 azioni dopo le transazioni. Tutti i grant sono stati riportati con un prezzo di $0, indicando che si tratta di premi azionari (equity awards) anziché acquisti sul mercato. La dichiarazione è firmata da un attorney-in-fact per conto della persona che presenta la segnalazione.
Kindly MD, Inc. (NAKA) recibió reportes de varios grants al Director Médico Timothy Pickett el 22/09/2025. El Formulario 4 muestra cuatro transacciones no derivativas que reportan la entrega de 37,593 unidades de acciones restringidas que se consolidan durante cuatro años con una cláusula de cliff de 12 meses, además de tres premios de acciones restringidas ya vencidos de 26,129, 10,146 y 18,378 acciones, elevando la propiedad reportada a 191,271 acciones tras las transacciones. Todos los grants se reportaron con un precio de $0, lo que indica que son premios de acciones (equity awards) y no compras en el mercado. La presentación está firmada por un poder judicial o apoderado en nombre de la persona reportante.
Kindly MD, Inc. (NAKA)의 내부자는 2025년 9월 22일 Timothy Pickett Chief Medical Officer에게 다수의 보조금을 보고했습니다. Form 4는 4년 동안 vests되는 37,593주의 제한 주식 단위와 12개월 시점 클리프를 포함한 비파생 거래 4건, 그리고 이미 확정된 26,129, 10,146, 18,378주가 보상으로 각각 지급된 3건의 제한 주식 보상으로 보고되며, 거래 후 보고된 유익 소유 주식 수는 191,271주로 증가합니다. 모든 보상은 시장 매입이 아닌 주식 보상임을 나타내는 $0의 가격으로 보고되었습니다. 해당 filing은 보고 당사자를 대신하여 대리인에 의해 서명되었습니다.
Un initié de Kindly MD, Inc. (NAKA) a reporté plusieurs attributions au Chief Medical Officer Timothy Pickett le 22/09/2025. Le formulaire Form 4 indique quatre transactions non dérivées correspondant à la réception de 37 593 unités d’actions restreintes qui s’acquièrent sur quatre ans avec une cliff de 12 mois, ainsi que trois attributions d’actions restreintes entièrement acquises de 26 129, 10 146, et 18 378 actions, portant la propriété bénéficiaire déclarée à 191 271 actions après les transactions. Tous les attributions ont été signalées à un prix de $0, indiquant qu’il s’agit d’avantages en actions (equity awards) plutôt que d’achats sur le marché. Le dossier est signé par un mandataire au nom de la personne qui déclare.
Ein Insider von Kindly MD, Inc. (NAKA) berichtete am 22.09.2025 über mehrere Zuwendungen an Chief Medical Officer Timothy Pickett. Das Form 4 listet vier nicht-derivative Transaktionen auf, bei denen 37.593 Restricted-Stock-Einheiten gewährt werden, die über vier Jahre mit einem 12-Monats- Cliff vesten, sowie drei vollständig vestierte Restricted-Stock-Boni von 26.129, 10.146 und 18.378 Aktien, wodurch sich das berichtete wirtschaftliche Eigentum nach den Transaktionen auf 191.271 Aktien erhöht. Alle Zuwendungen wurden mit einem Preis von $0 gemeldet, was darauf hinweist, dass es sich um Equity Awards handelt, nicht um Market Purchases. Die Einreichung ist von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.
FAQ
What insider transactions were reported for Kindly MD (NAKA)?
How do the reported RSUs vest for Timothy Pickett?
What is the reported beneficial ownership after these transactions?
Were any of the shares purchased at market price?
Who filed the Form 4 on behalf of the reporting person?
